纳米体介导的细胞吸收最大限度地提高了聚氨酸体的效力,同时保持了固体瘤的透能力
Daniel Yuen1, Orlagh M Feeney1, Leo Noi1
1Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia.
ACS nano
|February 6, 2025
概括
针对PEGylated树枝状体上的向纳米体增强了癌症药物输送. 这种策略改善了瘤细胞的吸收,并抑制了瘤的生长,优于非向载体.
科学领域:
- 纳米医学是一种纳米医学.
- 生物结合化学 生物结合化学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 登德里默是用于药物输送的多功能纳米载体,特别是用于癌症治疗的药物.
- 树突体的PEGylation增强了循环时间和瘤透.
- 向连接体可以改善树突基药物的特异性和细胞吸收.
研究的目的:
- 为了使瘤细胞向纳米体的单甲基奥里斯丁E (MMAE) 载荷的PEGylated树枝状体功能化.
- 评估单个纳米体结合对细胞吸收和治疗疗效的影响.
- 评估瘤生长抑制和固体瘤中向树枝状体的保留.
主要方法:
- 利用扩展的遗传代码和生物直角点击化学来实现树突细胞功能.
- 结合了单个瘤细胞向的纳米体与载有MMAE的PEGylated树突体.
- 评估瘤透,细胞吸收,瘤生长抑制和在HER2阳性瘤中保留.
主要成果:
- 统一的单个纳米体结合导致HER2阳性细胞的细胞内吸收增加.
- 向的树枝状体显示出明显更大的瘤生长抑制和长期保留.
- 仅仅生物分布研究是治疗性能的不良预测指标.
结论:
- 纳米体与树枝状体的受控结合增强了针对性的细胞吸收和治疗功效.
- 这种策略保持了树突体的优势,如大小和组织透,用于固体瘤治疗.
- 向树枝状体代表了改善癌症纳米药物疗效的有希望的方法.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
167
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
167
Site-Targeted Drug Delivery Systems: Polymeric Carriers
167
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
167


